Follow-up Calls for Colorectal Cancer Screening

Recruiting at 1 trial location

Age: 18 - 65

Sex: Any

Trial Phase: Academic

Sponsor: University of Southern California

Disqualifiers: Under 45, Over 59, Incarcerated, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

2135 Participants Needed

Trial Summary

What is the purpose of this trial?

This study aims to assess whether follow-up calls can increase the return rate of mailed FIT Kits. To assess this, a randomly selected half of eligible patients were randomized to receive a follow-up call reminding the patient to return the FIT Kit.

Eligibility Criteria

This trial is for individuals eligible for colorectal cancer screening. Specific eligibility criteria are not provided, but typically this includes adults of a certain age range or with risk factors for colorectal cancer. Details on who can't participate are not given.

Inclusion Criteria

I am between 45 and 59 years old.

Previously returned a FIT Kit

I am due for a colorectal cancer screening.

Exclusion Criteria

Incarcerated

I am not due for a colorectal cancer screening.

I am either younger than 45 or older than 59.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive a FIT Kit, with half receiving a follow-up call to encourage return

60 days

Follow-up

Participants are monitored for the return rate of the FIT Kit

4 weeks

Treatment Details

Interventions

• Phone call

Trial Overview The study is testing if follow-up phone calls increase the return rate of mailed FIT Kits used in colorectal cancer screening. Participants are split into two groups: one receives a reminder call, while the other does not.

Participant Groups

Group I: FIT Kit + Phone Call Experimental Treatment 2 Interventions

Patients sent a second FIT Kit and follow-up call to encourage completion and return of kit.

Group II: FIT Kit Only Active Control 1 Intervention

Patients sent a second FIT Kit.

Who Is Running the Clinical Trial?

University of Southern California

Lead Sponsor

Trials

956

Recruited

1,609,000+